Current issues in the management of patients with HIV infection and rheumatic diseases by G. I. Gridneva, B. S. Belov

Get full text

Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations by E. S. Aronova, B. S. Belov, G. I. Gridneva

Get full text

COVID-19 and post-covid syndrome in patients with rheumatoid arthritis by E. S. Aronova, B. S. Belov, G. I. Gridneva

Get full text

Retention on tofacitinib therapy in patients with rheumatoid arthritis (real clinical practice data) by G. I. Gridneva, E. S. Aronova, B. S. Belov

Get full text

Chronic hepatitis B in hospitalized rheumatologic patients: problems of screening and reactivation of infection by G. I. Gridneva, E. S. Aronova, B. S. Belov

Get full text

Viral mixed infection complicated by acute hepatitis and allergic toxic dermatitis (clinical case) by E. S. Aronova, B. S. Belov, G. I. Gridneva

Get full text

Post-Covid syndrome: clinical picture, diagnosis and treatment from a rheumatologist perspective by E. S. Aronova, B. S. Belov, G. I. Gridneva

Get full text

Is vaccination against viral hepatitis B safe and immunogenic in patients with rheumatic diseases? by G. I. Gridneva, B. S. Belov, E. S. Aronova

Get full text

Vaccine Prophylaxis of Herpes Zoster In Rheumatic Diseases: Paradigm Revision and New Opportunities by G. I. Gridneva, B. S. Belov, E. S. Aronova

Get full text

Revisiting the question of the safety of glucocorticoids use of in the treatment of rheumatoid arthritis by E. A. Aronova, B. S. Belov, G. I. Gridneva

Get full text

Factors associated with rs1801394 of the methionine synthase reductase gene polymorphism in patients with rheumatoid arthritis by M. Yu. Krylov, G. I. Gridneva, Yu. V. Muravyev

Get full text

Parvovirus B19 infection and its role in rheumatology by G. I. Gridneva, B. S. Belov, M. S. Tolbeeva, E. S. Aronova

Get full text

Chronic and opportunistic infections in patients with immuno-inflammatory rheumatic diseases: screening and prevention issues (based on the materials of the EULAR recommendations) by B. S. Belov, G. I. Gridneva, E. S. Aronova, E. L. Nasonov

Get full text

Rheumatoid arthritis and COVID-19: Three years later by B. S. Belov, E. S. Aronova, G. I. Gridneva, E. I. Nasonov

Get full text

The reaction of the skin and its appendages in rheumatoid arthritis patients using subcutaneous methotrexate: A description of three cases by Yu. V. Muravyev, G. I. Gridneva, S. G. Radenska-Lopovok, N. I. Kharitonova

Get full text

SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS by Yu. V. Muravyev, G. I. Gridneva, D. E. Karateev, E. L. Luchichina

Get full text

What do we know about the possibility of predicting the potential efficacy and safety of methotrexate, by measuring the concentration of its metabolites in rheumatoid arthritis? by G. I. Gridneva, E. S. Aronova, V. S. Sygyrta, A. V. Kudryavtseva, K. S. Nurbaeva

Get full text

Efficacy and safety of the Gam-COVID-Vac in patients with immunoinflammatory rheumatic diseases: preliminary data of prospective study by A. N. Kulikov, N. V. Muravyeva, B. S. Belov, G. I. Gridneva, E. S. Aronova

Get full text

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS by G. I. Gridneva, Yu. V. Muravyev, E. L. Luchikhina, N. V. Demidova, D. E. Karateev

Get full text

Analysis of the relationship between the response to methotrexate therapy and its pharmacokinetic parameters in rheumatoid arthritis. Sovremennaya Revmatologiya by G. I. Gridneva, Yu. V. Muravyov, S. I. Glukhova, E. S. Aronova, E. Yu. Samarkina, N. V. Baimeeva

Get full text